Background: Contrast echocardiography has been shown to improve endocardial border visualization and also increase the sensitivity in detecting left ventricular thrombus. In October 2007, the Federal Drug Agency issued a black box warning for contrast agents used in patients undergoing echocardiography. This safety concern has been disproven by several studies. We aim to provide data to support the safety of ultrasound contrast and demonstrate an expanded role of contrast agents in the diagnosis of atrial thrombi.
